Alphamed Formulations Profile
Key Indicators
- Authorised Capital ₹ 95.00 Cr
- Paid Up Capital ₹ 81.93 Cr
- Company Age 18 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.50 M
- Satisfied Charges ₹ 2.10 Cr
- Revenue Growth 15.87%
- Profit Growth -88.95%
- Ebitda -69.29%
- Net Worth 29.33%
- Total Assets 32.67%
About Alphamed Formulations
Alphamed Formulations Private Limited (AFPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 November 2006 and has a history of 18 years and four months. Its registered office is in Rangareddy, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 95.00 Cr and a paid-up capital of Rs 81.93 Cr.
The company currently has active open charges totaling ₹9.50 M. The company has closed loans amounting to ₹2.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Alphamed Formulations Private Limited India is Sudheer Gundu as COMPANY SECRETARY. Lorraine Hill, Ramesh Cheruvu, and Chris Botha serve as directors at the Company.
Company Details
- Location
Rangareddy, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239TG2006PTC051732
- Company No.
051732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Nov 2006
- Date of AGM
27 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Pharma
What products or services does Alphamed Formulations Private Limited offer?
Alphamed Formulations Private Limited offers a wide range of products and services, including Eye Drops, Olopatadine HCL, API Intermediate, Timolol Maleate Solution.
Who are the key members and board of directors at Alphamed Formulations?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sudheer Gundu  | Company Secretary | 13-Jun-2019 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Lorraine Hill  | Director | 12-Jun-2018 | Current |
| Ramesh Cheruvu | Whole-Time Director | 12-Jun-2018 | Current |
Chris Botha  | Director | 13-Oct-2023 | Current |
Financial Performance of Alphamed Formulations.
Alphamed Formulations Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.87% increase. The company also saw a substantial fall in profitability, with a 88.95% decrease in profit. The company's net worth Soared by an impressive increase of 29.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alphamed Formulations?
In 2023, Alphamed Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹0.95 Cr
Satisfied Charges
₹2.10 Cr
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Sep 2023 | State Bank Of India | ₹9.50 M | Open |
| 27 Aug 2008 | State Bank Of India | ₹0.95 M | Satisfied |
| 24 Aug 2007 | State Bank Of India | ₹2.00 Cr | Satisfied |
How Many Employees Work at Alphamed Formulations?
Alphamed Formulations has a workforce of 562 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alphamed Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alphamed Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Alphamed Formulations
Recent activity within the organization
- Charges
A charge with State Bank Of India of Rs. 0.95 Cr registered on 29 Sep 2023 with Charge ID 100795318 was modified on 19 Dec 2024.
- Annual General Meeting
Alphamed Formulations Private Limited last Annual general meeting of members was held on 27 Sep 2024 as per latest MCA records.
- Balance Sheet
Alphamed Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
- Director Appointment
Chris Mynhard Botha was appointed as a Director was appointed as a Director on 13 Oct 2023 & has been associated with this company since 1 year 5 months .
- Charges
A charge registered on 24 Aug 2007 via Charge ID 10065860 with State Bank Of India was fully satisfied on 05 Oct 2023.
- Charges
A charge with State Bank Of India amounted to Rs. 0.95 Cr with Charge ID 100795318 was registered on 29 Sep 2023.
Recent News, Updates & Announcement
Laurus Labs Acquires Phekolong Pharmaceuticals for ZAR 75,000, Expands Reach in South African ARV Market.Laurus Labs buys Phekolong Pharmaceuticals for ZAR 75,000. Deal to be done by November. Laurus gets access to South African ARV market, while Aspen will still make ARVs for public sector. Laurus also makes APIs for cancer and other diseases..
- Aspen Strikes Deal With India’s Laurus to Cut Cost of HIV Drugs.
Aspen plans to license intellectual property rights owned by Laurus..
Frequently asked questions
What is the Incorporation or founding date of Alphamed Formulations Private Limited?
Alphamed Formulations Private Limited was incorporated on 20 Nov 2006.
What is authorized share capital and paid-up capital of Alphamed Formulations Private Limited?
The authorized share capital of Alphamed Formulations Private Limited is ₹ 95.00 Cr and paid-up capital is ₹ 81.93 Cr.
Who are the current board members & directors of Alphamed Formulations Private Limited?
Currently 4 directors are associated with Alphamed Formulations Private Limited.
- Lorraine Angela Hill
- Ramesh Cheruvu
- Sudheer Reddy Gundu
- Chris Mynhard Botha
What is the registered address of Alphamed Formulations Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Alphamed Formulations Private Limited is Survey No. 225 Sampanbole Village Mandal, India, Shamirpet, Telangana, 500078.
What is the corporate identification number (CIN) and company number of Alphamed Formulations Private Limited?
The corporate identification number (CIN) of Alphamed Formulations Private Limited is U24239TG2006PTC051732 and the company number is 051732 as per Ministry of Corporate Affairs (MCA).
What is the official website of Alphamed Formulations Private Limited?
The Official website of Alphamed Formulations Private Limited is https://www.aspenpharma.com
What has been the recent revenue trend for Alphamed Formulations Private Limited?
According to the financial reports for the fiscal year 2023, the revenue trend for Alphamed Formulations Private Limited has risen by 15.87%.
How many employees does Alphamed Formulations Private Limited currently have?
As Per 2023 financial reports, 562 employees are currently employed by Alphamed Formulations Private Limited.
What change has been observed in the net worth of Alphamed Formulations Private Limited, and by what percentage?
The financial reports for the fiscal year 2023 indicates that The net worth of Alphamed Formulations Private Limited has experienced an upsurge of 29.33%.
What are the total open charges for Alphamed Formulations Private Limited?
As per the financial statements for fiscal Year 2023, The total open charges for Alphamed Formulations Private Limited amount to ₹ 9.50 M.
When was the last Balance Sheet of Alphamed Formulations Private Limited filed with the ROC?
The most recent Balance Sheet for Alphamed Formulations Private Limited was filed with the ROC on 31 Mar 2024.
People also Viewed
RR
Rabah RafaDirectorVB
Vikram BeryDirectorSG
Shekhar GangulaManaging DirectorAV
Ashok VasudevanDirectorBT
Bala ThippabhotlaWholetime Director